🇺🇸 FDA
Patent

US 7955596

B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production

granted A61PA61P31/04

Quick answer

US patent 7955596 (B. anthracis prevention and treatment: mutant B. anthracis lacking luxs activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production) held by UNIVERSITY OF CONNECTICUT expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P31/04